TEHRAN- The head of the Atomic Energy Agency of Iran (AEOI) on Sunday applauded the countrys significant accomplishments in nuclear medical technology and stated that various high-tech items, including radiopharmaceuticals, are planned to be exported.Speaking on the sidelines of the 29th Iranian Nuclear Conference, Mohammad Eslami told press reporters that the nations nuclear experts had actually made some impressive developments in the present Iranian year, which will finish on March 20.

Iran has actually developed a blood clot powder that is used to stop managing hemorrhage during major surgeries, he stated, stressing that the country had been denied of such a medical supply due to the fact that of global sanctions.The powder has actually gotten approval from Irans Food and Drug Administration and may now be sold to other countries, Eslami continued.He likewise commended the nuclear specialists for coming up with a fresh method to utilizing plasma innovation to cure garbage leachate.Certain targets and plans in the nuclear sector have actually been produced, according to the official, who prompted universities to collaborate with the AEOI in order to pave the way for the fields development and technological promotion.Eslami highlighted the initiatives to increase potential customers for research in nuclear technology and said that Iranian radiopharmaceuticals and nuclear medical equipment are currently being supplied to foreign countries.The AEOI head declared in December 2022 that Iran wants to become a significant producer of deuterium pharmaceuticals.In the not-too-distant future we will end up being a center for producing deuterium-based medications that are good alternative to chemical pharmaceuticals and have lower side effects in comparison to those treatments, he predicted.In April 2021, the AEOI started running the second stage of its deuterium production unit at the Arak heavy water reactor complex in the central Iran.